Literature DB >> 29511548

Citrulline as a marker of intestinal function and absorption in clinical settings: A systematic review and meta-analysis.

Konstantinos C Fragkos1, Alastair Forbes2.   

Abstract

BACKGROUND: Citrulline has been described as a marker of intestinal function or absorption but evidence varies according to clinical settings.
OBJECTIVE: The objective of this article is to examine the evidence of plasma citrulline as a marker of intestinal function and absorption in various clinical settings.
METHODS: Studies were examined for p values, means and standard deviations, correlation coefficients or other metrics depicting the association of citrulline with intestinal function. A random effects model was used to produce a pooled estimate. A hierarchical summary receiver operating curve model was fitted for diagnostic accuracy measures.
RESULTS: Citrulline levels are correlated strongly with small bowel length in short bowel syndrome patients (r = 0.67). Citrulline is strongly negatively correlated (r = -0.56) with intestinal disease severity with regards to enteropathies (coeliac disease, tropical enteropathy, Crohn's disease, mucositis, acute rejection in intestinal transplantation). Citrulline cut-off levels have an overall sensitivity and specificity of 80% and 84% respectively. Citrulline levels in untreated coeliac patients compared to controls were reduced by 10 µmol/l. Citrulline levels increase with gluten-free diet and with improvement of enteropathy. Citrulline is decreased in critical illness and sepsis.
CONCLUSION: These findings allow us to advocate quite reasonably that citrulline is a marker of acute and chronic intestinal insufficiency.

Entities:  

Keywords:  Citrulline; enteropathy; meta-analysis; short bowel syndrome; systematic review

Year:  2017        PMID: 29511548      PMCID: PMC5833233          DOI: 10.1177/2050640617737632

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  45 in total

1.  Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.

Authors:  Ludy C H W Lutgens; Nicole M A Blijlevens; Nicolaas E P Deutz; J Peter Donnelly; Philippe Lambin; Ben E de Pauw
Journal:  Cancer       Date:  2005-01-01       Impact factor: 6.860

2.  Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome.

Authors:  J Marc Rhoads; Emily Plunkett; Joseph Galanko; Steven Lichtman; Lesli Taylor; Angela Maynor; Timothy Weiner; Katherine Freeman; J Lindhe Guarisco; Guo Yao Wu
Journal:  J Pediatr       Date:  2005-04       Impact factor: 4.406

3.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2009-07-23       Impact factor: 6.437

4.  Plasma citrulline levels in paediatric patients with celiac disease and the effect of a gluten-free diet.

Authors:  Harikleia P Ioannou; Maria Fotoulaki; Aikaterini Pavlitou; Ioannis Efstratiou; Persephone Augoustides-Savvopoulou
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-03       Impact factor: 2.566

5.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

6.  An association of lower serum citrulline levels within 30 days of acute rejection in patients following small intestine transplantation.

Authors:  A I David; J J Gaynor; P P Zis; L Conanan; L Goldsmith; V Esquenazi; G Selvaggi; D Weppler; S Nishida; J Moon; J R Madariaga; P Ruiz; T Kato; D M Levi; G Kleiner; P Tryphonopoulos; A G Tzakis
Journal:  Transplant Proc       Date:  2006 Jul-Aug       Impact factor: 1.066

7.  Blood citrulline level is an exclusionary marker for significant acute rejection after intestinal transplantation.

Authors:  Andre I David; Gennaro Selvaggi; Phillip Ruiz; Jeffrey J Gaynor; Panagiotis Tryphonopoulos; Gary I Kleiner; Jang I Moon; Seigo Nishida; Peter A Pappas; Lobella Conanan; Debbie Weppler; Violet Esquenazi; David M Levi; Tomoaki Kato; Andreas G Tzakis
Journal:  Transplantation       Date:  2007-11-15       Impact factor: 4.939

8.  Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production.

Authors:  Yvette C Luiking; Martijn Poeze; Graham Ramsay; Nicolaas E P Deutz
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

9.  Defining normal plasma citrulline in intestinal transplant recipients.

Authors:  Gabriel E Gondolesi; Stuart S Kaufman; Claude Sansaricq; Margret S Magid; Kimiyo Raymond; Liesl P Iledan; Ye Tao; Sander S Florman; Neal S LeLeiko; Thomas M Fishbein
Journal:  Am J Transplant       Date:  2004-03       Impact factor: 8.086

10.  Plasma citrulline is a marker of absorptive small bowel length in patients with transient enterostomy and acute intestinal failure.

Authors:  Denis Picot; Laurence Garin; Florence Trivin; Michel P Kossovsky; Dominique Darmaun; Ronan Thibault
Journal:  Clin Nutr       Date:  2009-09-09       Impact factor: 7.324

View more
  29 in total

1.  Nutritional and metabolic regulation of the metabolite dimethylguanidino valeric acid: an early marker of cardiometabolic disease.

Authors:  Jibran A Wali; Yen Chin Koay; Jason Chami; Courtney Wood; Leo Corcilius; Richard J Payne; Roman N Rodionov; Andreas L Birkenfeld; Dorit Samocha-Bonet; Stephen J Simpson; John F O'Sullivan
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-07-14       Impact factor: 4.310

2.  A Subset of Patients With Autism Spectrum Disorders Show a Distinctive Metabolic Profile by Dried Blood Spot Analyses.

Authors:  Rita Barone; Salvatore Alaimo; Marianna Messina; Alfredo Pulvirenti; Jean Bastin; Alfredo Ferro; Richard E Frye; Renata Rizzo
Journal:  Front Psychiatry       Date:  2018-12-07       Impact factor: 4.157

3.  How to manage a high-output stoma.

Authors:  Jeremy M D Nightingale
Journal:  Frontline Gastroenterol       Date:  2021-03-22

Review 4.  Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives.

Authors:  Dimitris Kounatidis; Natalia G Vallianou; Dimitrios Tsilingiris; Gerasimos Socrates Christodoulatos; Eleni Geladari; Theodora Stratigou; Irene Karampela; Maria Dalamaga
Journal:  Curr Nutr Rep       Date:  2022-08-06

5.  Tryptophan oxidation in young children with environmental enteric dysfunction classified by the lactulose rhamnose ratio.

Authors:  Nirupama Shivakumar; Jean W Hsu; Sindhu Kashyap; Tinku Thomas; Anura V Kurpad; Farook Jahoor
Journal:  Am J Clin Nutr       Date:  2022-10-06       Impact factor: 8.472

Review 6.  Emerging Biomarkers for Screening and Management of Celiac Disease.

Authors:  Bilal Ahmad Mir; Tahir Majeed; Alka Singh; Mahendra Singh Rajput; Asheesh Kumar; Ashish Chauhan
Journal:  Biomed Res Int       Date:  2022-05-28       Impact factor: 3.246

7.  Citrulline Generation Test: What Does It Measure?

Authors:  Mahmoud A Mohammad; Inka C Didelija; Barbara Stoll; Juan C Marini
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-10-24       Impact factor: 4.016

Review 8.  Biochemical markers of acute intestinal ischemia: possibilities and limitations.

Authors:  Martina Montagnana; Elisa Danese; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2018-09

9.  The Serum Citrulline and D-Lactate are Associated with Gastrointestinal Dysfunction and Failure in Critically Ill Patients.

Authors:  Jin Teng; Lu Xiang; Huaicong Long; Caiping Gao; Lei Lei; Yinghui Zhang
Journal:  Int J Gen Med       Date:  2021-08-03

10.  Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients.

Authors:  Leila B Giron; Harsh Dweep; Xiangfan Yin; Han Wang; Mohammad Damra; Aaron R Goldman; Nicole Gorman; Clovis S Palmer; Hsin-Yao Tang; Maliha W Shaikh; Christopher B Forsyth; Robert A Balk; Netanel F Zilberstein; Qin Liu; Andrew Kossenkov; Ali Keshavarzian; Alan Landay; Mohamed Abdel-Mohsen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.